Applying Equianalgesic Dosing Calculations

Activity Preview

This module will provide you with the tools you need to assess changes to your patients' opioid therapy. 

Learning Level: 2
Activity Type:  Knowledge-based
Target Audience: Pharmacists

At the completion of this knowledge-based activity, participants will be able to:

  1. Describe equianalgesic equivalents between different opioid medications.
  2. State accepted approaches to dose reductions when switching between different opioid medications to account incomplete tolerance.
  3. State accepted approaches to dose reductions when switching between immediate-release and extended-release/long-acting dosage formulations or transmucosal/transdermal/intravenous/oral dosage routes.

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following activity is approved for 0.5 contact hour of CPE credit (0.05 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-282-H01-P.

To obtain credit for completing Applying Equianalgesic Dosing Calculations, complete the learning activity, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript. 

Initial release date: October 21, 2019

Expiration date: October 21, 2022

Development

Applying Equianalgesic Dosing Calculations is an online educational activity for pharmacists developed by the American Pharmacists Association.

Disclosures

APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association. 

Fee

There is no fee associated with this activity.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-19-282-H01-P 0.05 CEUs October 21, 2019 - October 21, 2022